Seduced by a P-value

Anaesthesia and Intensive Care

Volumn 42, Issue 5, 2014, Pages 551-554

  McIlroy, D ^a  

^a NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HUMAN; PROBABILITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS;

DATA INTERPRETATION, STATISTICAL; HUMANS; PROBABILITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84907943374     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1404200502     Document Type: Editorial

References (15)

1. Dorsey ER, de Roulet J, Thompson JP, Reminick JI, Thai A, White-Stellato Z et al. Funding of US biomedical research, 2003-2008. JAMA 2010; 303:137-143.
2. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988; 2:349-360.
3. Greenberg RS, Bembea M, Heitmiller E. Rainy days for the Society for Pediatric Anesthesia. Anesth Analg 2012; 114:1102-1103.
4. Counsell CE, Clarke MJ, Slattery J, Sandercock PA. The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis? BMJ 1994; 309:1677-1681.
5. Sun X, Briel M, Busse JW, You JJ, Akl EA, Mejza F et al. Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ 2012; 344:e1553.
6. Sun X, Briel M, Walter SD, Guyatt GH. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ 2010; 340:c117.
7. Sun X, Ioannidis JPA, Agoritsas T, Alba AC, Guyatt G. How to use a subgroup analysis: users' guide to the medical literature. JAMA 2014; 311:405-411.
8. Walsh M, Srinathan SK, McAuley DF, Mrkobrada M, Levine O, Ribic C et al. The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index. J Clin Epidemiol 2014; 67:622-628.
9. Goodman SN. A comment on replication, p-values and evidence. Stat Med 1992; 11:875-879.
10. Dahabreh IJ, Kent DM. Can the learning health care system be educated with observational data? JAMA 2014; 312:129-130.
11. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340:c869.
12. Myles PS, Leslie K, Chan MTV, Forbes A, Paech MJ, Peyton P et al. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology 2007; 107:221-231.
13. Myles PS, Leslie K, Peyton P, Paech MJ, Forbes A, Chan MTV et al. Nitrous oxide and perioperative cardiac morbidity (ENIGMA-II) Trial: rationale and design. Am Heart J 2009; 157:488-494.
14. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008; 371:1839-1847.
15. Sanfilippo F, Santonocito C, Foex P. Use of beta-blockers in non-cardiac surgery: an open debate. Minerva Anestesiol 2014; 80:482-494.